These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 389641)

  • 1. Dissociation between drug-induced increases in nerve terminal and non-nerve terminal pools of GABA in vivo.
    Iadarola MJ; Gale K
    Eur J Pharmacol; 1979 Oct; 59(1-2):125-9. PubMed ID: 389641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo effects of aminooxyacetic acid and valproic acid on nerve terminal (synaptosomal) GABA levels in discrete brain areas of the rat. Correlation to pharmacological activities.
    Löscher W; Vetter M
    Biochem Pharmacol; 1985 May; 34(10):1747-56. PubMed ID: 3924047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate enhances GABA turnover in the substantia nigra.
    Löscher W
    Brain Res; 1989 Oct; 501(1):198-203. PubMed ID: 2508993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the substantia nigra in GABA-mediated anticonvulsant actions.
    Gale K
    Adv Neurol; 1986; 44():343-64. PubMed ID: 3010676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo effects of anticonvulsant drugs on nerve terminal (synaptosomal) GABA levels in 11 brain regions of the rat.
    Löscher W; Vetter M; Böhme G; Stoltenburg-Didinger G
    J Neural Transm; 1985; 63(2):157-67. PubMed ID: 3930660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seizure protection and increased nerve-terminal GABA: delayed effects of GABA transaminase inhibition.
    Gale K; Iadarola MJ
    Science; 1980 Apr; 208(4441):288-91. PubMed ID: 6768130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of di-n-propylacetate, gabaculine, and aminooxyacetic acid: anticonvulsant activity and the gamma-aminobutyrate system.
    Wood JD; Kurylo E; Tsui SK
    J Neurochem; 1981 Dec; 37(6):1440-7. PubMed ID: 6801201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GABA-like immunoreactivity in different cellular populations of cerebellar cortex of rats before and after treatment with amino-oxyacetic acid.
    Palmi M; Brooke S; Smith AD; Bolam JP
    Brain Res; 1991 Mar; 543(2):277-86. PubMed ID: 2059835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between drug-induced increases of GABA levels in discrete brain areas and different pharmacological effects in rats.
    Löscher W; Vetter M
    Biochem Pharmacol; 1984 Jun; 33(12):1907-14. PubMed ID: 6428417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quasi-morphine withdrawal behaviour: indication for a specific involvement of the GABA-ergic nerve terminal compartment.
    van der Laan JW
    Life Sci; 1983; 33 Suppl 1():389-92. PubMed ID: 6420629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of inhibitors of GABA-transaminase on hole-board exploration and on temperature. Relation with effects on quasi-morphine abstinence behaviour induced by sodium dipropylacetate.
    van der Laan JW; Weick G; van Bleek G
    Biochem Pharmacol; 1985 Nov; 34(21):3789-94. PubMed ID: 3933514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High affinity uptake of GABA in presumed GABA-ERGIC nerve endings in rat brain.
    Storm-Mathisen J
    Brain Res; 1975 Feb; 84(3):409-27. PubMed ID: 1122379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of acute and subacute treatment with ergot drugs on the GABA system in specific brain regions.
    Pericić D
    J Pharm Pharmacol; 1981 Oct; 33(10):655-9. PubMed ID: 6117619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo release of newly synthesized [3H]GABA in the substantia nigra of the rat: relative contribution of GABA striato-pallido-nigral afferents and nigral GABA neurons.
    Lantin le Boulch N; Truong-Ngoc NA; Gauchy C; Besson MJ
    Brain Res; 1991 Sep; 559(2):200-10. PubMed ID: 1794098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of milacemide, a glycinamide derivative, on the rat brain gamma-aminobutyric acid system.
    de Varebeke PJ; Niebes P; Pauwels G; Roba J; Korf J
    Biochem Pharmacol; 1983 Sep; 32(18):2751-5. PubMed ID: 6414480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of n-dipropylacetate and amino-oxyacetic acid on gamma-aminobutyric acid levels in discrete areas of rat brain.
    Iadarola MJ; Raines A; Gale K
    J Neurochem; 1979 Nov; 33(5):1119-23. PubMed ID: 387917
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tranquilizing effect of n-dipropylacetate and other GABA-ergic substances in conflict situations].
    Kharlamov AN; Raevskiĭ KS
    Biull Eksp Biol Med; 1980 Jul; 89(7):35-7. PubMed ID: 6773597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-induced changes in GABA content of nerve endings in 11 rat brain regions. Correlation to pharmacological effects.
    Löscher W; Vetter M
    Neurosci Lett; 1984 Jun; 47(3):325-31. PubMed ID: 6089052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The level of GABA in the brain and locomotor behavior.
    Grimm V; Gottesfeld Z; Wassermann I; Samuel D
    Pharmacol Biochem Behav; 1975; 3(4):573-8. PubMed ID: 1103159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.